| Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants JI Warrick, G Sjödahl, M Kaag, JD Raman, S Merrill, L Shuman, G Chen, ... European urology 75 (1), 18-22, 2019 | 202 | 2019 |
| An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer SV Lindskrog, F Prip, P Lamy, A Taber, CS Groeneveld, ... Nature communications 12 (1), 2301, 2021 | 176 | 2021 |
| Wnt/β-catenin activation promotes prostate tumor progression in a mouse model X Yu, Y Wang, DJ DeGraff, ML Wills, RJ Matusik Oncogene 30 (16), 1868-1879, 2011 | 145 | 2011 |
| FOXA1, GATA3 and PPARɣ cooperate to drive luminal subtype in bladder cancer: a molecular analysis of established human cell lines JI Warrick, V Walter, H Yamashita, E Chung, L Shuman, VO Amponsa, ... Scientific reports 6 (1), 38531, 2016 | 143 | 2016 |
| Mouse models of prostate cancer: picking the best model for the question MM Grabowska, DJ DeGraff, X Yu, RJ Jin, Z Chen, AD Borowsky, ... Cancer and Metastasis Reviews 33, 377-397, 2014 | 121 | 2014 |
| Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes JJ Meeks, H Al-Ahmadie, BM Faltas, JA Taylor III, TW Flaig, DJ DeGraff, ... Nature Reviews Urology 17 (5), 259-270, 2020 | 113 | 2020 |
| Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation DJ DeGraff, PE Clark, JM Cates, H Yamashita, VL Robinson, X Yu, ... PloS one 7 (5), e36669, 2012 | 112 | 2012 |
| Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone R Jin, JA Sterling, JR Edwards, DJ DeGraff, C Lee, SI Park, RJ Matusik PloS one 8 (4), e60983, 2013 | 103 | 2013 |
| NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression MM Grabowska, AD Elliott, DJ DeGraff, PD Anderson, G Anumanthan, ... Molecular endocrinology 28 (6), 949-964, 2014 | 77 | 2014 |
| Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis S Choudhary, P Hegde, JR Pruitt, TM Sielecki, D Choudhary, K Scarpato, ... Carcinogenesis 34 (12), 2891-2899, 2013 | 71 | 2013 |
| Loss of FOXA1 drives sexually dimorphic changes in urothelial differentiation and is an independent predictor of poor prognosis in bladder cancer OL Reddy, JM Cates, LL Gellert, HS Crist, Z Yang, H Yamashita, ... The American journal of pathology 185 (5), 1385-1395, 2015 | 70 | 2015 |
| Tailoring peptidomimetics for targeting protein–protein interactions ON Akram, DJ DeGraff, JH Sheehan, WD Tilley, RJ Matusik, JM Ahn, ... Molecular Cancer Research 12 (7), 967-978, 2014 | 61 | 2014 |
| SOX2 expression in the developing, adult, as well as, diseased prostate X Yu, JM Cates, C Morrissey, C You, MM Grabowska, J Zhang, ... Prostate cancer and prostatic diseases 17 (4), 301-309, 2014 | 53 | 2014 |
| Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions DJ DeGraff, AA Aguiar, RA Sikes American Journal of Translational Research 1 (2), 115, 2009 | 53 | 2009 |
| When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression DJ DeGraff, JM Cates, JR Mauney, PE Clark, RJ Matusik, RM Adam Urologic Oncology: Seminars and Original Investigations 31 (6), 802-811, 2013 | 51 | 2013 |
| FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype DJ DeGraff, MM Grabowska, TC Case, X Yu, MK Herrick, WJ Hayward, ... Laboratory investigation 94 (7), 726-739, 2014 | 49 | 2014 |
| Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes H Li, Q Zhang, L Shuman, M Kaag, JD Raman, S Merrill, DJ DeGraff, ... Scientific reports 10 (1), 1439, 2020 | 46 | 2020 |
| Suppression of p16 induces mTORC1-mediated nucleotide metabolic reprogramming R Buj, CW Chen, ES Dahl, KE Leon, R Kuskovsky, N Maglakelidze, ... Cell reports 28 (8), 1971-1980. e8, 2019 | 44 | 2019 |
| FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma JI Warrick, M Kaag, JD Raman, W Chan, T Tran, S Kunchala, L Shuman, ... Virchows Archiv 471, 337-345, 2017 | 44 | 2017 |
| Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma M Russo, JM Newell, L Budurlean, KR Houser, K Sheldon, J Kesterson, ... Cancer 126 (12), 2775-2783, 2020 | 41 | 2020 |
Jay RamanPenn State HealthVerified email at pennstatehealth.psu.edu
